# Johnson & Johnson (JNJ): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/jnj for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Drug Manufacturers - General
- Exchange: NYSE · Trading currency: USD

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr...

## Quote & Key Metrics

As of 2026-10-28:

| Metric | Value |
|---|---|
| Price | $271.04 USD |
| Market Cap | $652.48B |
| P/E (TTM) | 25.45 |
| EPS (TTM) | $10.65 |
| 52-Week Range | $184.66 – $281.07 |
| Dividend Yield (TTM) | 1.95% |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | 1.95% |
| Annual Dividend (TTM) | $5.28 /share |
| Annual Dividend (Forward) | $5.36 /share |
| Frequency | Quarterly |
| Consecutive Growth Streak | 64 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | 3.1% / 4.0% / 4.8% / 5.3% |
| Payout Ratio (EPS, TTM) | 80.1% |
| Payout Ratio (FCF, TTM) | 62.8% |
| Payout Ratio (EPS, forward dividend) | 81.3% |
| Payout Ratio (FCF, forward dividend) | 63.7% |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2026-11-24 | $1.3400 | 2026-12-08 |
| 2026-08-25 | $1.3400 | 2026-09-08 |
| 2026-05-26 | $1.3400 | 2026-06-09 |
| 2026-02-24 | $1.3000 | 2026-03-10 |
| 2025-11-25 | $1.3000 | 2025-12-09 |
| 2025-08-26 | $1.3000 | 2025-09-09 |
| 2025-05-27 | $1.3000 | 2025-06-10 |
| 2025-02-18 | $1.2400 | 2025-03-04 |
| 2024-11-26 | $1.2400 | 2024-12-10 |
| 2024-08-27 | $1.2400 | 2024-09-10 |
| 2024-05-20 | $1.2400 | 2024-06-04 |
| 2024-02-16 | $1.1900 | 2024-03-05 |

Full history: https://www.dividenddata.com/stocks/jnj/dividend

## Frequently Asked Questions

### What does Johnson & Johnson do?

Johnson & Johnson (JNJ) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is JNJ's market cap?

Johnson & Johnson (JNJ) has a market capitalization of approximately $652.48 billion, as of October 28, 2026, based on the most recent share price and shares outstanding.

### Does JNJ pay a dividend?

Yes, Johnson & Johnson (JNJ) pays a dividend quarterly, with a trailing-twelve-month yield of 1.95%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

### How often does JNJ pay dividends?

Johnson & Johnson pays dividends quarterly. The forward annual rate is $5.36 per share at the current declared cadence. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is JNJ's payout ratio?

Johnson & Johnson's payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

### Is JNJ a Dividend Aristocrat?

Yes, Johnson & Johnson (JNJ) is an S&P 500 Dividend Aristocrat, meaning it has raised its dividend for at least 25 consecutive years. Its full dividend history and growth rates are on this page.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/jnj
- Dividend history & safety: https://www.dividenddata.com/stocks/jnj/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/jnj/earnings
- Financial statements: https://www.dividenddata.com/stocks/jnj/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/jnj/valuation
- Peer comparison: https://www.dividenddata.com/stocks/jnj/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.